Laurion Capital Management LP Amphastar Pharmaceuticals, Inc. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$19.12 - $22.62 $256,055 - $302,927	-13,392 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$18.92 - $22.96 $107,503 - $130,458	-5,682 Reduced 29.79%	13,392 $283,000
Q1 2019 May 08, 2019	BUY	$19.46 - $25.28 $371,180 - $482,190	19,074 New	19,074 $390,000
Q1 2018 May 14, 2018	SELL	$17.23 - $20.35 $294,633 - $347,985	-17,100 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$17.76 - $19.75 $303,696 - $337,725	17,100	17,100 $329,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.